Stock Analysts

Fed Approves BofA’s Capital Plan: A Dividend Hike in Cards?

Shares of Bank of America Corporation BAC closed modestly in the green on Thursday after the Federal Reserve approved the bank’s revised capital plan. The approval was declared through a press release wherein the Federal Reserve said that the company’s “progress in remediating the identified deficiencies in its capital planning processes” led to the sanction of its plan. Notably, at the Comprehensive Capital Analysis and Review (“CCAR”) in Mar 2015, the Federal Reserve had highlighted certain loopholes in BofA’s capital planning processes, including deficiency in loss & revenue modeling practices and internal controls. […]

Stock Analysts

Shell Appraises New Zealand Prospects Amid Oil Price Slump

The largest oil company in Europe Royal Dutch Shell plc RDS.A is looking to streamline its portfolio of global assets in the wake of persistent low commodity prices. This time, the company is assessing its business interests in New Zealand. To go into more details, Shell is planning to focus on operations with more prospects to partially counter the effects of the crude price slump […]

Stock Analysts

Priceline to Boost Stake in Ctrip with $500M Investment

Online travel booking company, Priceline.com PCLN announced that it will increase its stake in China's online travel company, Ctrip.com International, Ltd. CTRP , as part of its efforts to broaden its footprint in the world’s largest outbound-travel market. Priceline said it has agreed to invest an additional $500 million through a convertible bond along with an unnamed "long-term equity investment firm" […]

Stock Analysts

Puma (PBYI) Reports Data on Breast Cancer Drug PB272

Puma Biotechnology, Inc. PBYI announced interim results from the ongoing phase II study on PB272 (neratinib) for the treatment of patients with ERBB2 mutant, human epidermal growth factor receptor type 2 (HER2) non-amplified, metastatic breast cancer. Data were presented at the 2015 Cancer Therapy & Research Center – the American Association for Cancer Research (CTRC-AACR) San Antonio Breast Cancer Symposium. […]

Stock Analysts

AIG Appoints Team to Drive Returns; Will Icahn Be Pleased?

American International Group, Inc. 's AIG CEO Peter Hancock recently announced a new Executive Leadership Team structure, in a bid to make organizational operations smoother. The team, comprising 10 heads – all veterans in their respective fields – will work toward attaining the strategic priorities of the company […]

Stock Analysts

Should You Dump Qualcomm (QCOM) from Your Portfolio Now?

On Dec 10, 2015, we issued an updated research report on QUALCOMM Incorporated (QCOM) QCOM – the market leader in mobile chipsets. This Zacks Rank #5 (Strong Sell) company reported better-than-expected financial results in the fourth quarter of fiscal 2015 steering past the Zacks Consensus Estimate on both the top and the bottom-line front. However, Qualcomm has provided a soft outlook for non-GAAP earnings per share for the first quarter of fiscal 2016, estimating the same between 80 cents and 90 cents. […]